574 related articles for article (PubMed ID: 16873531)
1. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle.
Miyamoto L; Toyoda T; Hayashi T; Yonemitsu S; Nakano M; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Ogawa Y; Inoue G; Fushiki T; Nakao K
J Appl Physiol (1985); 2007 Mar; 102(3):1007-13. PubMed ID: 17122373
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB
PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811
[TBL] [Abstract][Full Text] [Related]
4. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
5. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside.
Bradley EA; Zhang L; Genders AJ; Richards SM; Rattigan S; Keske MA
Cardiovasc Diabetol; 2015 Jul; 14():91. PubMed ID: 26194188
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
8. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR--an activator of AMP-activated protein kinase.
Young ME; Radda GK; Leighton B
FEBS Lett; 1996 Mar; 382(1-2):43-7. PubMed ID: 8612761
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
Buhl ES; Jessen N; Schmitz O; Pedersen SB; Pedersen O; Holman GD; Lund S
Diabetes; 2001 Jan; 50(1):12-7. PubMed ID: 11147776
[TBL] [Abstract][Full Text] [Related]
10. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
11. AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1/MEK/p42/44MAPK/p90RSK/GSK-3 signaling cascade.
Wang HM; Mehta S; Bansode R; Huang W; Mehta KD
Biochem Pharmacol; 2008 Jan; 75(2):457-67. PubMed ID: 17945190
[TBL] [Abstract][Full Text] [Related]
12. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
13. Effect of AMPK activation on muscle glucose metabolism in conscious rats.
Bergeron R; Russell RR; Young LH; Ren JM; Marcucci M; Lee A; Shulman GI
Am J Physiol; 1999 May; 276(5):E938-44. PubMed ID: 10329989
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
15. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
16. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
Gaidhu MP; Fediuc S; Ceddia RB
J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
[TBL] [Abstract][Full Text] [Related]
18. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
